Current UCLA Urologic Oncology Fellows:
Izak Faiena, MD
Dr. Faiena received his medical degree from Albert Einstein College of Medicine and completed a general surgery internship and urology residency at Rutgers Robert Wood Johnson Medical School. Dr. Faiena’s research interests center on the advancements in immunotherapy and how they have radically changed the landscape of cancer therapeutics. A particular focus area is the discovery of new treatment options for advanced bladder cancer using immunotherapeutic strategies using a patient’s own immune cells. Dr. Faiena plans to spend a third year of fellowship training with the IUO in order to complete advanced training in conducting clinical research. He will be awarded a Masters Degree in Translational Investigation at UCLA. More >
David Johnson, MD
Dr. Johnson joined the IUO from the University of North Carolina, Chapel Hill following his Urologic Surgery Residency. Dr. Johnson is currently involved in health services research with a focus on value-based care redesign and alternative payment models in urologic cancer care. The aim is to systematically evaluate processes of care surrounding localized prostate and kidney cancer treatment in order to determine drivers of cost and quality. Ultimately, the goal is to maximize the value of care we deliver throughout the institution and provide a model for other health care organizations to follow that want to redesign their care processes to lower cost and quality. In addition, Dr. Johnson is working on establishing a collaboration with the Cuban Ministry of Health to improve the early detection and treatment of prostate cancer in Cuba.
Aydin Pooli, MD
Dr. Aydin Pooli received his medical degree from Tehran University of Medical Sciences. After a few years of research in reconstructive surgery and minimally invasive surgery, He underwent three years of training for general surgery at Montefiore Medical Center and the University of Nebraska Medical Center. He completed his Urologic Surgery residency at the University of Nebraska Medical Center. Dr. Pooli is interested in personalized, patient-centered management of urologic cancers including targeted diagnostic tools (imagine guided sampling, genomics) as well as delivery of targeted immunologic therapy and tailored surgical procedures to each specific urologic cancer. Dr. Pooli will be investigating the relationships among clinical, radiologic, pathologic and genomic profile of patients with kidney, urothelial and prostate cancers.
Joseph Shirk, MD Dr. Shirk received his medical degree from the Medical College of Wisconsin. He completed his intern year in general surgery at Boston Medical Center, and his urology residency at UCLA. His interests are in technology innovation that improves care for patients with urologic malignancies. He is currently involved in research to provide surgeons and patients with advanced 3D imaging to assist in both the understanding of disease and the performance of operations. Ultimately, the goal is to change the landscape of imaging for surgical planning and improve patient outcomes. More >